Article Information
History
- April 22, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Michael P. McRae1,
- Glennon W. Simmons1,
- Nicolaos J. Christodoulides1,
- Zhibing Lu4,*,
- Stella K. Kang5,
- David Fenyo6,
- Timothy Alcorn7,
- Isaac P. Dapkins8,
- Iman Sharif9,
- Deniz Vurmaz10,
- Sayli S. Modak1,
- Kritika Srinivasan12,
- Shruti Warhadpande1,
- Ravi Shrivastav1 and
- John T. McDevitt1,*
- 1Department of Biomaterials, Bioengineering Institute, New York University, New York, NY, USA
- 4Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
- 5Departments of Radiology, Population Health New York University School of Medicine, New York, NY, USA
- 6Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA
- 7Latham BioPharm Group, Cambridge, MA, USA
- 8Department of Population Health and Internal Medicine, New York University School of Medicine, New York, NY, USA
- 9Departments of Pediatrics and Population Health, New York University School of Medicine, New York, NY, USA
- 10Department of Chemical and Biomolecular Engineering, NYU Tandon School of Engineering, New York University, New York, NY, USA
- 12Departments of Biomaterials, Pathology, New York University School of Medicine, New York University, New York, NY, USA
- ↵*Corresponding Authors John T. McDevitt, Department of Biomaterials, Bioengineering Institute, New York University, 433 First Avenue, Room 820, New York, NY 10010-4086, USA. Email: mcdevitt{at}nyu.edu. Phone: 212-998-9204., Zhibing Lu, Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China. Email: luzhibing222{at}163.com.
Posted April 22, 2020.
Clinical Decision Support Tool and Rapid Point-of-Care Platform for Determining Disease Severity in Patients with COVID-19
